期刊文献+

HPLC-MS/MS法测定清洁验证中残留物卡前列素氨丁三醇的含量 被引量:2

Determination of carboprost tromethamine residue in cleaning validation by HPLC-MS/MS
下载PDF
导出
摘要 目的建立一种HPLC-MS/MS方法测定清洁验证中卡前列素氨丁三醇的残留量。方法实验中所用色谱柱为Hypersil GOLD C_(18)(100 mm×2.1 mm,3μm)柱;以水(A)-甲醇(B)为流动相,梯度洗脱;柱温:35℃;流速:0.4 mL·min^(-1);进样量:2μL;以电喷雾电离源(electrospray ionization,ESI)为离子源,以多反应监测方式(multiple reaction monitoring,MRM)进行负离子扫描。结果卡前列素氨丁三醇在质量浓度4.316~24.90μg·L^(-1)内与峰面积具有良好的线性关系(r=0.999),回收率为92.8%,RSD为5.6%。结论所建立的HPLC-MS/MS法特异性强、灵敏度高,适用于卡前列素氨丁三醇残留量的测定。 Objective To establish an HPLC-MS/MS method for the determination of carboprost tromethamine residue in cleaning validation.Methods The method was carried out with Hypersil GOLD C_(18)column(100 mm×2.1 mm,3μm).The mobile phase was consisted of water(A)-methanol(B)with gradient elution at a flow rate of 0.4 mL·min^(-1)at 35℃.The injection volume was 2μL.The analyte was detected by negative electrospray ionization(ESI)combined with multiple reaction monitoring(MRM)mode.Results Carboprost tromethamine showed a good linearity in the range of 4.316-24.90μg·L^(-1)(r=0.999).The recovery was 92.8%and the RSD was 5.6%.Conclusion The HPLC-MS/MS method is of high specificity and sensitivity.It can be used for the determination of carboprost tromethamine residue.
作者 佟明慧 杨肖 李清 张倩 TONG Minghui;YANG Xiao;LI Qing;ZHANG Qian(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2022年第1期17-23,共7页 Journal of Shenyang Pharmaceutical University
基金 国家重大新药创制科技重大专项“药物一致性评价关键技术与标准研究”(2017ZX09101001) 辽宁省特聘教授项目(李清)。
关键词 清洁验证 卡前列素氨丁三醇 残留量测定 HPLC-MS/MS cleaning validation carboprost tromethamine residue determination HPLC-MS/MS
  • 相关文献

参考文献7

二级参考文献43

  • 1梁毅,蔡江波.对中药制剂设备清洁验证的探讨[J].中国药房,2005,16(9):651-653. 被引量:14
  • 2郑宋英,陈媛,郑邦一.卡前列素氨丁三醇联合缩宫素预防产后出血的效果观察[J].护理学报,2006,13(4):72-72. 被引量:2
  • 3闻国春.新型肌肉松弛药—罗库溴铵研究进展[J].河北医药,2007,29(7):742-743. 被引量:3
  • 4国家食品药品监督管理局药品生产验证指南[M].北京:化学工业出版社,2003.
  • 5BAI J,SUN Q,ZHAI H. A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high- risk patients undergoing cesarean delivery [ J ]. Exp Ther Med, 2014,7(1) :46 -50.
  • 6CHU KO,WANG CC,PANG CP,et al. Method to determine sta- bility and recovery of carboprost and misoprostol in infusion prep- arations [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007,857(1) :83 -91.
  • 7AGARWAL U,NANDA S,SANGWAN K,et al. Combined blad- der and uterine rupture following prostaglandin-indnced midtrime- ster abortion: an unreported event [ J ]. Acta Obstet Gynecol Scand, 2003,82 ( 10 ) : 974 - 975.
  • 8LOESER E,SUTTON P,SKORODINSKY A,et al. Chemical in- teractions between an active pharmaceuticalingredient and its counterion in a tromethamine salt underforced degradation condi- tions[ J]. Drug Dev Ind Pharm ,2012,38 ( 3 ) :357 - 364.
  • 9United States Pharmacopeial Convention. USP35-NF30 [ S]. Rockville : National Formulary ,2012:2498 - 2499.
  • 10SMITH AL, HAIDER K, SCHACHTNER JM,et al. Fatal hemoly- sis after high-dose etoposide:is benzyl alcohol to blame? [ J ]. Pharmacotherapy,2001,21 (6) :764 - 766.

共引文献35

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部